A Case of Chronic Incomplete Vogt-Koyanagi-Harada (VKH) Disease with Systemic Involvement in a 57-Year-Old Woman
Downloads
Introduction: Vogt–Koyanagi–Harada (VKH) disease is a systemic disorder that involves tissues containing pigmented cells. It is thought to be caused by an autoimmune T-cell-mediated process against melanocytes in systemic organs, particularly the eyes. VKH disease is a chronic, bilateral, diffuse, granulomatous panuveitis that involves integumentary, neurologic, and auditory aspects, which affects females and darkly pigmented ethnic groups. Here, we presented a rare case of VKH disease in a seronegative spondyloarthropathy patient. Case Presentation: A 57-year-old woman complaining of blurry vision in both eyes for three years. She was previously diagnosed with spondyloarthropathy, osteoarthritis, type 2 diabetes, hypertension, and dyslipidemia. Both eyelids exhibited periocular vitiligo and poliosis and were slightly hyperemic. Both eyes had perilimbal vitiligo and fine brown keratic precipitates. The anterior chambers were deep and quiet; however, the patient had posterior synechiae in both eyes. The fundus examination showed a sunset glow fundus appearance. Conclusions: VKH is a chronic disease that can relapse and recur. While the disease's prognosis is overall favorable, it is determined by the duration and frequency of recurrent inflammation episodes; thus, early detection and prompt treatment are essential for success. Poor visual prognosis is predicted by a larger number of complications, an older age at disease onset, a longer median duration of the disease, delayed treatment initiation, and a higher number of recurrent episodes of inflammation. To preserve vision, patients often require lifelong immunosuppressive therapy and need to be educated about the signs and symptoms to watch for when their condition relapses.
Giordano VE, Schlaen A, Guzmán-Sánchez MJ, Couto C. Spectrum and visual outcomes of Vogt-Koyanagi-Harada disease in Argentina. Int J Ophthalmol 2017;10:98–102. https://doi.org/10.18240/ijo.2017.01.16.
Urzua CA, Herbort CP, Takeuchi M, Schlaen A, Concha-Del-Rio LE, Usui Y, et al. Vogt-Koyanagi-Harada disease: The step-by-step approach to a better understanding of clinicopathology, immunopathology, diagnosis, and management: a brief review. J Ophthalmic Inflamm Infect 2022;12:17. https://doi.org/10.1186/s12348-022-00293-3.
Ataei Y, Samara WA, Felton WL, Brar VS. Incomplete Vogt-Koyanagi-Harada in a 14-year-old African American female with bilateral disc edema. Am J Ophthalmol Case Rep 2021;22:101114. https://doi.org/10.1016/j.ajoc.2021.101114.
Lipps J, Khan MA. Vogt–Koyanagi–Harada syndrome: A rheumatologic perspective. Int J Clin Rheumtol 2010;5:255–263. https://doi.org/10.2217/ijr.10.2.
American Academy of Ophthalmology. Uveitis and Ocular Inflammation. In: Sen H, Albini T, Burkholder B, Dahr S, Dodds E, Leveque T, et al., editors. 2022-2023 BCSC - Basic and Clinical Science Course, Section 9, San Francisco: American Academy of Ophthalmology; 2022.
Gandhi P, Hussain S, Shah A, Reddy Y. Asymmetric and incomplete Vogt-Koyanagi–Harada syndrome: Patient’s perceptive dilemma. TNOA J Ophthalmic Sci Res 2022;60:318. https://doi.org/10.4103/tjosr.tjosr_49_22.
Papasavvas I, Herbort CP. Vogt-Koyanagi-Harada disease is always bilateral: Reports of unilateral cases failed to use choroidal investigations showing subclinical involvement of the fellow eye. J Ophthalmic Inflamm Infect 2021;11:6. https://doi.org/10.1186/s12348-021-00237-3.
Shrestha P, Sharma S, Kharel R. Vogt-Koyanagi-Harada disease: A case series in a Tertiary Eye Center. Case Rep Ophthalmol Med 2021;2021:8848659. https://doi.org/10.1155/2021/8848659.
Rasheed R, Shah K, Pillai GS, Mithun C, Radhakrishnan N, Kandula P. A perplexing case of bilateral Vogt-Koyanagi-Harada syndrome. Indian J Ophthalmol Case Rep 2022;2:120–122. https://doi.org/10.4103/ijo.IJO_1522_21.
Suzuki S. Quantitative evaluation of “Sunset Glow” fundus in Vogt–Koyanagi–Harada disease. Jpn J Ophthalmol 1999;43:327–333. https://doi.org/10.1016/S0021-5155(99)00016-7.
AlBahkaly S, AlKhunaizi A, Algamdi Z. Vogt-Koyanagi-Harada syndrome (review of case reports). Egypt J Otolaryngol 2012;28:275–277. https://doi.org/10.7123/01.EJO.0000418070.27183.f7.
Far NY, Liu DTL. Probable Vogt-Koyanagi-Harada disease with initial unilateral ocular manifestation in a hepatitis C carrier. J Ophthalmic Inflamm Infect 2012;2:235–237. https://doi.org/10.1007/s12348-012-0082-x.
Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: Report of an international committee on nomenclature. Am J Ophthalmol 2001;131:647–652. https://doi.org/10.1016/s0002-9394(01)00925-4.
Stern E, Nataneli N. Vogt-Koyanagi-Harada Syndrome. StatPearls [Internet] 2023. https://www.ncbi.nlm.nih.gov/books/NBK574571/ (accessed April 2, 2025).
American Academy of Ophthalmology. Vogt-Koyanagi-Harada Disease. Eye Wiki 2025. https://eyewiki.org/Vogt-Koyanagi-Harada_Disease (accessed April 2, 2025).
Copyright (c) 2025 Camilla A. Prakoeswa, Ismi Zuhria

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Vision Science and Eye Health Journal by Universitas Airlangga is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The journal allows the author to hold the copyright of the article without restrictions.
The journal allows the author(s) to retain publishing rights without restrictions.
The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Share-Alike (CC BY-SA).
The Creative Commons Attribution-Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violations.